Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX5 | P09917 | 2/20 | 0.61 |
| ▸ | BACE1 | P56817 | 1/20 | 0.58 |
| ▸ | HSD17B10 | Q99714 | 4/20 | 0.56 |
| ▸ | HPGD | P15428 | 3/20 | 0.56 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.56 |
| ▸ | BCL2L1 | Q07817 | 1/20 | 0.56 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.50 |
| ▸ | TSHR | P16473 | 2/20 | 0.50 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.50 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.48 |
| ▸ | MEN1 | O00255 | 3/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.47 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.47 |
| ▸ | LMNA | P02545 | 1/20 | 0.47 |
| ▸ | MAPT | P10636 | 1/20 | 0.47 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.47 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.47 |
| ▸ | ESR2 | Q92731 | 2/20 | 0.47 |
| ▸ | CA1 | P00915 | 1/20 | 0.47 |
| ▸ | CA2 | P00918 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28016335 | 0.86 | HSD17B10 (0.54) | ALOX5HSD17B10HPGDALDH1A1CYP3A4 | |
| SCHEMBL29383789 | 0.84 | BACE1 (0.62) | ALOX5BACE1HSD17B10HPGDALDH1A1 | |
| SCHEMBL329155 | 0.84 | BACE1 (0.62) | ALOX5BACE1HSD17B10HPGDALDH1A1 | |
| Phosphine SCHEMBL27555075 | 0.83 | BACE1 (0.60) | ALOX5BACE1HSD17B10HPGDALDH1A1 | |
| Methane SCHEMBL27581120 | 0.83 | BACE1 (0.60) | ALOX5BACE1HSD17B10HPGDALDH1A1 | |
| SCHEMBL31104724 | 0.82 | BACE1 (0.44) | ALOX5BACE1HSD17B10HPGDALDH1A1 | |
| SCHEMBL5050876 | 0.81 | CYP1A2 (0.52) | ALOX5BACE1HSD17B10HPGDALDH1A1 | |
| SCHEMBL28637714 | 0.81 | ALOX15 (0.56) | BACE1HSD17B10HPGDALDH1A1CYP3A4 | |
| SCHEMBL339112 | 0.80 | HSD17B10 (0.65) | ALOX5HSD17B10HPGDALDH1A1CYP3A4 | |
| SCHEMBL28097322 | 0.79 | BACE1 (0.56) | ALOX5BACE1HSD17B10HPGDALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220407012-A1 | ORGANIC COMPOUND, ORGANIC LIGHT-EMITTING DIODE INCLUDING ORGANIC COMPOUND, AND DISPLAY DEVICE INCLUDING ORGANIC LIGHT-EMITTING DIODE | SOULBRAIN CO., LTD. (KR) | 2022-12-22 | — | — | US | disclosed |
| EP-4053119-A1 | ORGANIC COMPOUND, ORGANIC LIGHT-EMITTING DIODE COMPRISING SAME, AND DISPLAY DEVICE COMPRISING ORGANIC LIGHT-EMITTING DIODE | Soulbrain Co., Ltd. (KR) | 2022-09-07 | — | — | EP | disclosed |
| WO-2021086143-A1 | ORGANIC COMPOUND, ORGANIC LIGHT-EMITTING DIODE COMPRISING SAME, AND DISPLAY DEVICE COMPRISING ORGANIC LIGHT-EMITTING DIODE | 솔브레인 주식회사 | 2021-05-06 | — | — | WO | disclosed |
| CN-109843053-A | The purposes of supersaturated water-based system is used to prepare through surface reacting calcium carbonate | OMYA国际股份公司 | 2019-06-04 | — | — | CN | disclosed |
| US-8187473-B2 | Functional transition metal silicates | Raju, Kanumuru Rahul (IN) | 2012-05-29 | — | — | US | disclosed |
| EP-1939175-A1 | SULFONAMIDE DERIVATIVE HAVING PGD2 RECEPTOR ANTAGONISTIC ACTIVITY | Shionogi&Co., Ltd. (JP) | 2008-07-02 | — | — | EP | disclosed |
| US-20060281961-A1 | Functional transition metal silicates | KANUMURU RAHUL RAJU (IN) | 2006-12-14 | — | — | US | disclosed |
| EP-1670719-A1 | FUNCTIONAL TRANSITION METAL SILICATES (FTMS) | RAJU, Kanumuru Rahul (IN) | 2006-06-21 | — | — | EP | disclosed |
| WO-2004101435-A1 | FUNCTIONAL TRANSITION METAL SILICATES (FTMS) | RAJU, KANUMURU, RAHUL (IN) | 2004-11-25 | — | — | WO | disclosed |
| US-4472421-A | SHAMPOO | BAYER AKTIENGESELLSCHAFT (DE) | 1984-09-18 | — | — | US | disclosed |
| US-4360469-A | Preparation of quinones by salcomine-catalyzed oxidation of phenols | EASTMAN KODAK COMPANY (US) | 1982-11-23 | — | — | US | disclosed |
| US-4000299-A | 1-(Imidazol-1-yl)-1-[4-(4-chlorophenyl)phenoxy]-3,3-dimethylbutan-2-one, its salts and a process for their use | BAYER AKTIENGESELLSCHAFT (DT) | 1976-12-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220407012-A1 | ORGANIC COMPOUND, ORGANIC LIGHT-EMITTING DIODE INCLUDING ORGANIC COMPOUND, AND DISPLAY DEVICE INCLUDING ORGANIC LIGHT-EMITTING DIODE | OCIAD1, AOX1, OXER1 | ALOX5 248/4885BACE1 305/4885HSD17B10 760/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.